Science
Future Outlook And Stock Price Performance For Silexion Therapeutics Corp (NASDAQ: SLXN)
In today’s recent session, 8.66 million shares of the Silexion Therapeutics Corp (NASDAQ:SLXN) have been traded, and its beta is 0.05. Most recently the company’s